1-9 of 9
Lu Liu
Close
Sort by
Journal Articles

A Single Institutional Experience Using Avatrombopag to Manage Severe and Refractory Treatment Related Thrombocytopenia in Solid Tumor and Hematologic Malignancy Patients

Linlin Shao, Lu Liu, Yu Hou, Xiaolin Zhang, Lin Wang, Shuqian Xu, Ping Qin, Qiang Song, Jun Peng, Ming Hou, Yan Shi
Journal: Blood
Blood (2023) 142 (Supplement 1): 5447.
https://doi.org/10.1182/blood-2023-188831
Published: 2023
Journal Articles

The Association of pDC Dose in Graft with CMV and EBV Infection after Allo-HSCT in Pediatric Patients: A Single-Center Experience

Di Yao, Bohan Li, Lu Liu, Lijun Meng, Shaoyan Hu, Yuanyuan Tian
Journal: Blood
Blood (2022) 140 (Supplement 1): 10527.
https://doi.org/10.1182/blood-2022-170635
Published: 2022
Journal Articles

ER-associated degradation preserves hematopoietic stem cell quiescence and self-renewal by restricting mTOR activity

Lu Liu, Ayaka Inoki, Kelly Fan, Fengbiao Mao, Guojun Shi, Xi Jin, Meiling Zhao, Gina Ney, Morgan Jones, Shengyi Sun, Yali Dou, Ken Inoki, Ling Qi, Qing Li
Journal: Blood
Blood (2020) 136 (26): 2975–2986.
https://doi.org/10.1182/blood.2020007975
Published: 2020
Includes: Supplemental data
Journal Articles

Comparison of Subcutaneous Injection Versus Intravenous Infusion of Cytarabine for Induction Therapy in Young Adult Acute Myeloid Leukemia: Results of a Prospective, Multicenter, Noninferiority, Randomized Trial

Huafeng Wang, MD, LU LIU, MD, Jianfeng Zhou, MD PhD, Jianyong Li, MD PhD, Ying Lu, MD, Jianping Shen, MD, Chunyan Ji, MD, Tong Chen, MD PhD, Kang Yu, MD, Hanyun Ren, MD, Yan Li, MD, Dengju Li, MD, Ying Chen, MD, Shaolei Zang, MD, Bin Liang, MD, Sijing Kang, MD, Jinghan Wang, MDPhD, Wei Cheng, PhD, Haitao Meng, MD PhD, Wen-Juan Yu, Yanhong Tong, Honghu Zhu, MD, Jie Jin, MD PhD
Journal: Blood
Blood (2020) 136 (Supplement 1): 4.
https://doi.org/10.1182/blood-2020-143426
Published: 2020
Journal Articles

Caudal Type Homeobox 2 Is Required for Leukemogenesis but Not for Normal Hematopoieisis

Morgan A Jones, MD PhD BS, MS, Meiling Zhao, MS, Lu Liu, PhD, Ying Feng, PhD, Adam Ross, Eric R Fearon, MD PhD, Qing Li, MD PhD
Journal: Blood
Blood (2019) 134 (Supplement_1): 3770.
https://doi.org/10.1182/blood-2019-130985
Published: 2019
Journal Articles

Hyperactive Nras and Dose Reduction of Tet2 Collaborate to Dys-Regulate Hematopoietic Stem Cells and Promote Leukemogenesis

Xi Jin, PhD, Tingting Qin, PhD, Nathanael G Bailey, MD, Meiling Zhao, MS, Kevin B Yang, Victor Ng, MS, Lu Liu, PhD, Rosemary Coolon, MS, Gina Ney, MD PhD, Maria E Figueroa, MD, Qing Li, MD PhD
Journal: Blood
Blood (2016) 128 (22): 1204.
https://doi.org/10.1182/blood.V128.22.1204.1204
Published: 2016
Journal Articles

N-RasG12D-Mediated Dysregulation of IRE1alpha-Xbp1s Signaling Promotes Pre-Leukemic Hematopoietic Stem Cell Expansion

Lu Liu, PhD, Meiling Zhao, MS, Kevin B Yang, Xi Jin, PhD, Gina Ney, MD PhD, Juan Del Valle, BS, PhD, Takao Iwawaki, PhD, Qing Li, MD PhD
Journal: Blood
Blood (2016) 128 (22): 567.
https://doi.org/10.1182/blood.V128.22.567.567
Published: 2016
Journal Articles

Oncogenic Nras Grants Apoptosis Resistance to Hematopoietic Stem Cells

Kevin B Yang, Victor Ng, MS, Gina Ney, MD PhD, Lu Liu, PhD, Xi Jin, PhD, Qing Li, MD PhD
Journal: Blood
Blood (2015) 126 (23): 2451.
https://doi.org/10.1182/blood.V126.23.2451.2451
Published: 2015
Journal Articles

Dysregulation of PSTPIP2 Due to Loss of GATA-1 Contributes to Aberrant Megakaryopoiesis

Lu Liu, Shangqin Liu, Sr., Qiang Jeremy Wen, MD, PhD, John Crispino, PhD, Zan Huang
Journal: Blood
Blood (2012) 120 (21): 854.
https://doi.org/10.1182/blood.V120.21.854.854
Published: 2012